X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (91) 91
chemoradiotherapy (87) 87
humans (85) 85
female (67) 67
oncology (66) 66
male (60) 60
aged (58) 58
middle aged (57) 57
chemotherapy (54) 54
radiotherapy (53) 53
cancer (52) 52
surgery (45) 45
adult (43) 43
crt (34) 34
prognosis (29) 29
3d-crt (28) 28
radiation-therapy (26) 26
survival (26) 26
treatment outcome (26) 26
care and treatment (24) 24
imrt (23) 23
radiation therapy (23) 23
retrospective studies (23) 23
aged, 80 and over (22) 22
carcinoma (22) 22
esophageal cancer (22) 22
chemoradiation (21) 21
neoplasm staging (21) 21
radiology, nuclear medicine & medical imaging (21) 21
therapy (20) 20
rectal cancer (19) 19
original (18) 18
patients (18) 18
gastroenterology & hepatology (17) 17
radiation (17) 17
disease-free survival (16) 16
medicine & public health (16) 16
rectal neoplasms - pathology (16) 16
research (16) 16
carcinoma, squamous cell - pathology (15) 15
carcinoma, squamous cell - therapy (15) 15
hematology, oncology and palliative medicine (15) 15
squamous-cell carcinoma (15) 15
trial (15) 15
colorectal cancer (14) 14
adenocarcinoma (13) 13
chemoradiotherapy - methods (13) 13
neoadjuvant therapy (13) 13
original article (13) 13
preoperative chemoradiotherapy (13) 13
radiotherapy dosage (13) 13
radiotherapy, conformal - methods (13) 13
rectal neoplasms - therapy (13) 13
analysis (12) 12
combined modality therapy (12) 12
survival rate (12) 12
toxicity (12) 12
adenocarcinoma - pathology (11) 11
adenocarcinoma - therapy (11) 11
squamous cell carcinoma (11) 11
cancer therapies (10) 10
colorectal-cancer (10) 10
concurrent chemoradiotherapy (10) 10
esophageal neoplasms - pathology (10) 10
esophageal neoplasms - therapy (10) 10
lung cancer (10) 10
medical prognosis (10) 10
neoadjuvant chemoradiotherapy (10) 10
pancreatic cancer (10) 10
radiology (10) 10
randomized-trial (10) 10
recurrence (10) 10
risk factors (10) 10
survival analysis (10) 10
adjuvant treatment (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
carcinoma, squamous cell - radiotherapy (9) 9
cisplatin (9) 9
fluorouracil (9) 9
follow-up studies (9) 9
intensity-modulated radiotherapy (9) 9
metastasis (9) 9
multivariate analysis (9) 9
non-small cell lung cancer (9) 9
oncology, experimental (9) 9
phase-iii trial (9) 9
quality-of-life (9) 9
radiotherapy, intensity-modulated - methods (9) 9
respiratory system (9) 9
abridged index medicus (8) 8
article (8) 8
cancer patients (8) 8
chemoradiotherapy, adjuvant (8) 8
gemcitabine (8) 8
health aspects (8) 8
immunohistochemistry (8) 8
lymphatic metastasis (8) 8
neoplasms (8) 8
nsclc (8) 8
predictive value of tests (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Hepato-Biliary-Pancreatic Sciences, ISSN 1868-6974, 7/2012, Volume 19, Issue 4, pp. 413 - 425
We aimed to determine the relationship between the intratumoral expression of human equilibrative nucleoside transporter (hENT1), the main gemcitabine... 
Human equilibrative nucleoside transporter-1 (hENT1) | Pathology | Survival analysis | Medicine & Public Health | Diagnostic Radiology | Gemcitabine | Pancreatic cancer | Gastroenterology | Abdominal Surgery | Internal Medicine | Surgical Oncology | Chemoradiotherapy (CRT) | human equilibrative nucleoside transporter‐1 (hENT1) | pancreatic cancer | gemcitabine | chemoradiotherapy (CRT) | survival analysis | ADJUVANT CHEMOTHERAPY | DIHYDROPYRIMIDINE DEHYDROGENASE | SURGEONS CONTRIBUTION | MINIMAL POSTOPERATIVE COMPLICATIONS | LIVER PERFUSION CHEMOTHERAPY | LONG-TERM SURVIVAL | ADENOCARCINOMA | RANDOMIZED CONTROLLED-TRIAL | THYMIDYLATE SYNTHASE EXPRESSION | FULL-DOSE GEMCITABINE | GASTROENTEROLOGY & HEPATOLOGY | Immunohistochemistry | Multivariate Analysis | Adenocarcinoma - pathology | Pancreatic Neoplasms - metabolism | Prognosis | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Chemoradiotherapy, Adjuvant | Nutrition Assessment | Adenocarcinoma - metabolism | Aged, 80 and over | Adult | Female | Neoadjuvant Therapy | Pancreatic Neoplasms - mortality | CA-19-9 Antigen - blood | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - surgery | Biomarkers - analysis | Thymidylate Synthase - metabolism | Treatment Outcome | Equilibrative Nucleoside Transporter 1 - metabolism | Adenocarcinoma - therapy | Survival Analysis | Aged | Neoplasm Staging | Dihydrouracil Dehydrogenase (NADP) - metabolism | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Pancreatic Neoplasms - therapy | Multivariate analysis | Medical prognosis | Index Medicus
Journal Article
Pancreas, ISSN 0885-3177, 2014, Volume 43, Issue 3, pp. 350 - 360
This study aimed to evaluate the efficacy of gemcitabine-based chemoradiotherapy followed by surgery (gem-CRTS) for pancreatic ductal adenocarcinoma (PDAC) for... 
Human equilibrative nucleoside transporter 1 expression | Gemcitabine | Resectabilty | Pancreatic cancer | Preoperative chemoradiotherapy | Immunohistochemistry | Outcome Assessment (Health Care) - methods | Multivariate Analysis | Prognosis | Follow-Up Studies | Humans | Middle Aged | Male | Carcinoma, Pancreatic Ductal - surgery | Deoxycytidine - therapeutic use | CA-19-9 Antigen - analysis | Female | Equilibrative Nucleoside Transporter 1 - analysis | Chemoradiotherapy - methods | Pancreatic Neoplasms - surgery | Kaplan-Meier Estimate | Proportional Hazards Models | Pancreas - drug effects | Carcinoma, Pancreatic Ductal - therapy | Combined Modality Therapy | Pancreas - surgery | Antimetabolites, Antineoplastic - therapeutic use | Outcome Assessment (Health Care) - statistics & numerical data | Adenocarcinoma - therapy | Aged | Pancreas - radiation effects | Deoxycytidine - analogs & derivatives | Adenocarcinoma - surgery | Pancreatectomy - methods | Pancreatic Neoplasms - therapy | Index Medicus | CT - computed tomography | NCRT - neoadjuvant chemoradiotherapy | CA - celiac artery | hENT-1 - human equilibrative nucleoside transporter-1 | UR - unresectable | PV - portal vein | SMA - superior mesenteric artery | pancreatic cancer | EMT - epithelial-mesenchymal transition | SMV - superior mesenteric vein | MSTs - median survival times | preoperative chemoradiotherapy | R - resectable | PD - pancreaticoduodenectomy | gem-CRTS - gemcitabine-based chemoradiotherapy followed by surgery | DP - distal pancreatectomy | human equilibrative nucleoside transporter 1 expression | CRT - chemoradiotherapy | resectabilty | AC - adjuvant chemotherapy | BR - borderline resectable | EUS-FNA - endoscopic ultrasonography–guided fine-needle aspiration | PDAC - pancreatic ductal adenocarcinoma | MDCT - multidetector computed tomography | NCCN - National Comprehensive Cancer Network | gemcitabine | UICC - Union Internationale Contre le Cancer | Original
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 81, Issue 4, pp. 1017 - 1024
Purpose Preoperative chemoradiotherapy (CRT) is superior to radiotherapy (RT) in locally advanced rectal cancer, but the survival gain is limited. Late... 
Radiology | Hematology, Oncology and Palliative Medicine | Radiotherapy (RT) | Rectal cancer | Late toxicity | Nonresectable | Chemoradiotherapy (CRT) | SURGERY | FECAL INCONTINENCE | POSTOPERATIVE RADIOTHERAPY | SEXUAL FUNCTION | CHEMOTHERAPY | RADIATION-THERAPY | TRIAL | ONCOLOGY | CHEMORADIATION | QUALITY-OF-LIFE | DYSFUNCTION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Intestinal Obstruction - epidemiology | Chemoradiotherapy - adverse effects | Adenocarcinoma - pathology | Fecal Incontinence - epidemiology | Follow-Up Studies | Surgical Stomas - statistics & numerical data | Vagina - drug effects | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Radiotherapy - adverse effects | Vagina - radiation effects | Neoplasm Recurrence, Local - pathology | Fluorouracil - therapeutic use | Time Factors | Penile Erection - drug effects | Aged, 80 and over | Adult | Female | Leucovorin - therapeutic use | Surveys and Questionnaires | Rectal Neoplasms - pathology | Neoplasm Recurrence, Local - therapy | Tumor Burden | Rectal Neoplasms - therapy | Preoperative Care | Adenocarcinoma - therapy | Sex Factors | Sexuality | Quality of Life | Diagnostic Self Evaluation | Urinary Incontinence - epidemiology | Aged | Penile Erection - radiation effects | Research | Universities and colleges | Radiotherapy | Oncology, Experimental | Cancer | Index Medicus | PATIENTS | URACILS | NEOPLASMS | RECTUM | CITROVORUM FACTOR | TOXICITY | STANDARD OF LIVING | WOMEN | MEN | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | COMBINED THERAPY | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Translational Lung Cancer Research, ISSN 2218-6751, 04/2016, Volume 5, Issue 2, pp. 150 - 154
Chemotherapy is the mainstay of the treatment in limited disease (LD) and extended disease (ED) small cell lung cancer (SCLC) patients, while concurrent... 
Limited disease (LD) | Thoracic radiotherapy | Elderly | Chemoradiotherapy (CRT) | Small cell lung cancer (SCLC) | METAANALYSIS | THORACIC-RADIOTHERAPY | elderly | COMBINED-MODALITY TREATMENT | small cell lung cancer (SCLC) | limited disease (LD) | IRRADIATION | ETOPOSIDE | THERAPY | CISPLATIN | ONCOLOGY | RESPIRATORY SYSTEM | thoracic radiotherapy | CARCINOMA | AGE
Journal Article
Journal Article
Journal Article
British Journal of Cancer, ISSN 0007-0920, 05/2008, Volume 98, Issue 10, pp. 1670 - 1674
The zinc finger protein glioma-associated oncogene homologue 1 (Gli-1) is a critical component of the Hedgehog (Hh) signalling pathway, which is essential for... 
Cancer stem cell | Oesophageal cancer | Gli-1 | Chemoradiotherapy (CRT) | Hedgehog (Hh) | PROTEIN | SONIC HEDGEHOG | RADIATION | TUMORS | oesophageal cancer | THERAPY | cancer stem cell | GENE | ONCOLOGY | PATHWAY | SQUAMOUS-CELL CARCINOMA | chemoradiotherapy (CRT) | RECURRENCE | EXPRESSION | Immunohistochemistry | Predictive Value of Tests | Prognosis | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Hedgehog Proteins - metabolism | Carcinoma, Squamous Cell - surgery | Male | Antineoplastic Agents - therapeutic use | Esophageal Neoplasms - radiotherapy | Carcinoma, Squamous Cell - radiotherapy | Esophageal Neoplasms - pathology | Esophageal Neoplasms - surgery | Esophageal Neoplasms - metabolism | Biomarkers, Tumor - metabolism | Adult | Female | Retrospective Studies | Chemotherapy, Adjuvant | Esophageal Neoplasms - therapy | Radiotherapy, Adjuvant | Signal Transduction | Neoplasm Recurrence, Local | Carcinoma, Squamous Cell - therapy | Lymphatic Metastasis | Transcription Factors - metabolism | Disease-Free Survival | Carcinoma, Squamous Cell - drug therapy | Neoadjuvant Therapy - methods | Survival Analysis | Aged | Zinc Finger Protein GLI1 | Esophageal Neoplasms - drug therapy | Index Medicus | Molecular Diagnostics
Journal Article
Medicine (United States), ISSN 0025-7974, 04/2018, Volume 97, Issue 15
Journal Article
Journal Article
PANCREAS, ISSN 0885-3177, 04/2014, Volume 43, Issue 3, pp. 350 - 360
Journal Article
Clinical Lung Cancer, ISSN 1525-7304, 05/2019, Volume 20, Issue 3, pp. e256 - e264
This study was aimed at clarifying the failure pattern after definitive chemoradiotherapy in patients with stage III non–small-cell lung cancer (NSCLC)... 
ALK | Recurrence | CRT | NSCLC | EGFR | ADENOCARCINOMA | PHASE-III | MITOMYCIN | COMBINATION | CHEMOTHERAPY | CISPLATIN | ONCOLOGY | CHEMORADIATION | VINDESINE | THORACIC RADIOTHERAPY | CONCURRENT
Journal Article